Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins

Abstract

Statins are promising for breast cancer therapy; dipyridamole can potentiate their effects, but is contraindicated in some cases. Here, the authors develop a pharmacogenomics pipeline to predict other compounds that potentiate statins, and validate the top candidates in cell line screens and 3D cultures.